Literature DB >> 26100135

Unconventional screening approaches for antibiotic discovery.

Maya A Farha1, Eric D Brown1.   

Abstract

The dramatic rise in microbial drug resistance in recent years has led to ongoing searches for novel drugs to add to the armory against infectious disease. Nevertheless, a paucity of new antibacterial drugs in discovery and development pipelines using traditional approaches has prompted a variety of unconventional and disruptive strategies for antibacterial drug discovery. Herein, we review recent nontraditional approaches that have been piloted for early drug discovery efforts. These unique methodologies open new avenues for finding the next generation of antimicrobials.
© 2015 New York Academy of Sciences.

Entities:  

Keywords:  antibiotic discovery; high-throughput screening; unconventional methodologies

Mesh:

Substances:

Year:  2015        PMID: 26100135     DOI: 10.1111/nyas.12803

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  17 in total

Review 1.  Antibacterial drug discovery in the resistance era.

Authors:  Eric D Brown; Gerard D Wright
Journal:  Nature       Date:  2016-01-21       Impact factor: 49.962

2.  Prediction of multidimensional drug dose responses based on measurements of drug pairs.

Authors:  Anat Zimmer; Itay Katzir; Erez Dekel; Avraham E Mayo; Uri Alon
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-25       Impact factor: 11.205

3.  Endless Resistance. Endless Antibiotics?

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Medchemcomm       Date:  2015-11-03       Impact factor: 3.597

Review 4.  Predictive validity in drug discovery: what it is, why it matters and how to improve it.

Authors:  Jack W Scannell; James Bosley; John A Hickman; Gerard R Dawson; Hubert Truebel; Guilherme S Ferreira; Duncan Richards; J Mark Treherne
Journal:  Nat Rev Drug Discov       Date:  2022-10-04       Impact factor: 112.288

Review 5.  Drug repurposing for antimicrobial discovery.

Authors:  Maya A Farha; Eric D Brown
Journal:  Nat Microbiol       Date:  2019-03-04       Impact factor: 17.745

6.  Ribosome Assembly as Antimicrobial Target.

Authors:  Rainer Nikolay; Sabine Schmidt; Renate Schlömer; Elke Deuerling; Knud H Nierhaus
Journal:  Antibiotics (Basel)       Date:  2016-05-27

7.  Auxotrophy-based High Throughput Screening assay for the identification of Bacillus subtilis stringent response inhibitors.

Authors:  Liis Andresen; Vallo Varik; Yuzuru Tozawa; Steffi Jimmy; Stina Lindberg; Tanel Tenson; Vasili Hauryliuk
Journal:  Sci Rep       Date:  2016-10-24       Impact factor: 4.379

8.  Visualization of mycobacterial membrane dynamics in live cells.

Authors:  Frances P Rodriguez-Rivera; Xiaoxue Zhou; Julie A Theriot; Carolyn R Bertozzi
Journal:  J Am Chem Soc       Date:  2017-02-23       Impact factor: 15.419

Review 9.  Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing.

Authors:  Natalie K Boyd; Chengwen Teng; Christopher R Frei
Journal:  Front Cell Infect Microbiol       Date:  2021-05-17       Impact factor: 5.293

10.  A Deep Learning Approach to Antibiotic Discovery.

Authors:  Jonathan M Stokes; Kevin Yang; Kyle Swanson; Wengong Jin; Andres Cubillos-Ruiz; Nina M Donghia; Craig R MacNair; Shawn French; Lindsey A Carfrae; Zohar Bloom-Ackermann; Victoria M Tran; Anush Chiappino-Pepe; Ahmed H Badran; Ian W Andrews; Emma J Chory; George M Church; Eric D Brown; Tommi S Jaakkola; Regina Barzilay; James J Collins
Journal:  Cell       Date:  2020-02-20       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.